{
    "ticker": "HROWL",
    "name": "Harrow Health, Inc.",
    "description": "Harrow Health, Inc. is a healthcare company focused on the development and commercialization of innovative pharmaceutical products, particularly in the field of ophthalmology. Founded in 1983 and based in Nashville, Tennessee, Harrow Health aims to improve patient outcomes through unique formulations and delivery systems. The company specializes in sterile compounded pharmaceuticals and offers a range of products that address various eye conditions. Harrow Health's flagship product, Ilevro, is a non-steroidal anti-inflammatory drug (NSAID) used for the management of pain and inflammation following cataract surgery. The company is committed to advancing ophthalmic care through research and development, ensuring the availability of high-quality and affordable medications for patients. With a focus on patient-centric solutions, Harrow Health collaborates with healthcare professionals and institutions to provide effective treatments and enhance the overall quality of care. Harrow Health is also focused on expanding its product portfolio through strategic partnerships and acquisitions, further solidifying its position in the ophthalmic market.",
    "industry": [
        "Pharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "Nashville, Tennessee, USA",
    "founded": "1983",
    "website": "https://www.harrowhealth.com",
    "ceo": "Mark L. Baum",
    "social_media": {
        "twitter": "https://twitter.com/HarrowHealth",
        "linkedin": "https://www.linkedin.com/company/harrow-health"
    },
    "investor_relations": "https://ir.harrowhealth.com",
    "key_executives": [
        {
            "name": "Mark L. Baum",
            "position": "CEO"
        },
        {
            "name": "Mina Sooch",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Ophthalmic Pharmaceuticals",
            "products": [
                "Ilevro",
                "Compounded Sterile Preparations"
            ]
        }
    ],
    "seo": {
        "meta_title": "Harrow Health, Inc. | Innovative Ophthalmic Pharmaceuticals",
        "meta_description": "Harrow Health, Inc. is a leader in ophthalmic pharmaceuticals, dedicated to improving patient outcomes through innovative products like Ilevro. Explore our commitment to eye care and patient-focused solutions.",
        "keywords": [
            "Harrow Health",
            "Ophthalmology",
            "Pharmaceuticals",
            "Ilevro",
            "Eye Care"
        ]
    },
    "faq": [
        {
            "question": "What is Harrow Health known for?",
            "answer": "Harrow Health is known for its innovative ophthalmic pharmaceuticals, primarily focusing on products for eye health and surgery."
        },
        {
            "question": "Who is the CEO of Harrow Health?",
            "answer": "Mark L. Baum is the CEO of Harrow Health, Inc."
        },
        {
            "question": "Where is Harrow Health headquartered?",
            "answer": "Harrow Health is headquartered in Nashville, Tennessee, USA."
        },
        {
            "question": "What are Harrow Health's main products?",
            "answer": "Harrow Health's main products include Ilevro and various compounded sterile preparations for ophthalmic use."
        },
        {
            "question": "When was Harrow Health founded?",
            "answer": "Harrow Health was founded in 1983."
        }
    ],
    "competitors": [
        "AKRX",
        "PRGO",
        "BHC",
        "HUM"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "MRK",
        "JNJ"
    ]
}